CoMFA and CoMSIA investigations of dopamine D3 receptor ligands leading to the prediction, synthesis, and evaluation of rigidized FAUC 365 analogues

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 17, 2006, Pages 5898-5912

  Salama, Ismail ^a   Schlotter, Karin ^a   Utz, Wolfgang ^a   Hübner, Harald ^a   Gmeiner, Peter ^a   Boeckler, Frank ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

3D QSAR; CoMFA CoMSIA model; Dopamine D3 Receptor; Phenylpiperazine

Indexed keywords

ALKENE DERIVATIVE; BENZO[B]THIOPHENE 2 CARBOXYLIC ACID[2 (2,3 DICHLOROPHENYL) OCTAHYDROPYRIDO[1,2 A]PYRAZINE 7 YL]ETHYL AMIDE; BP 897; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; N[4 [4 (2,3 DICHLOROPHENYL)PIPERAZIN 1 YL]CYCLOHEXYL]BENZO[B]THIOPHENE 2 CARBOXAMIDE; RECEPTOR SUBTYPE; TRANS 1,4 CYCLOHEXYLENE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; CONFORMATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR AFFINITY; STATISTICAL SIGNIFICANCE;

COMBINATORIAL CHEMISTRY TECHNIQUES; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PIPERAZINES; PROTEIN BINDING; RECEPTORS, DOPAMINE D3; STRUCTURE-ACTIVITY RELATIONSHIP; THIOPHENES;

EID: 33746079592     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.05.025     Document Type: Article

References (51)

1. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., and Schwartz J.C. Nature 347 (1990) 146
2. Richtand N.M., Woods S.C., Berger S.P., and Strakowski S.M. Neurosci. Biobehav. Rev. 25 (2001) 427
3. Joyce J.N., and Millan M.J. Drug Discov. Today 10 (2005) 917
4. Joyce J.N., Ryoo H.L., Beach T.B., Caviness J.N., Stacy M., Gurevich E.V., Reiser M., and Adler C.H. Brain Res. 955 (2002) 138
5. Bezard E., Ferry S., Mach U., Stark H., Leriche L., Boraud T., Gross C., and Sokoloff P. Nat. Med. 9 (2003) 762
6. Pilla M., Perachon S., Sautel F., Garrido F., Mann A., Wermuth C.G., Schwartz J.C., Everitt B.J., and Sokoloff P. Nature 400 (1999) 371
7. Unis, A. S.; Roberson, M. D.; Hill, K.; Hamblin, M. W.; Dorsa, D. W. In: 25th Annual Meeting of the Society of Neuroscience, San Diego, CA, Nov 11-16, 1995; Society of Neuroscience: Washington, DC, 1995.
8. Boeckler, F.; Gmeiner, P. Pharmacol. Ther. 2006, in press.
9. Löber S., Hübner H., Utz W., and Gmeiner P. J. Med. Chem. 44 (2001) 2691
10. Löber S., Aboul-Fadl T., Hübner H., and Gmeiner P. Bioorg. Med. Chem. Lett. 12 (2002) 633
11. Löber S., Hübner H., and Gmeiner P. Bioorg. Med. Chem. Lett. 9 (1999) 97
12. Ortner B., Waibel R., and Gmeiner P. Angew. Chem., Int. Ed. 40 (2001) 1283
13. Newman A.H., Grundt P., and Nader M.A. J. Med. Chem. 48 (2005) 3663
14. Aston-Jones G., and Druhan J. Nature 400 (1999) 317
15. Boeckler F., Leng A., Mura A., Bettinetti L., Feldon J., Gmeiner P., and Ferger B. Biochem. Pharmacol. 66 (2003) 1025
16. Bettinetti L., Schlotter K., Hübner H., and Gmeiner P. J. Med. Chem. 45 (2002) 4594
17. Bettinetti L., Löber S., Hübner H., and Gmeiner P. J. Comb. Chem. 7 (2005) 309
18. Gmeiner, P.; Huebner, H.; Schlotter, K. WO2004004729, 2004.
19. Lanig H., Utz W., and Gmeiner P. J. Med. Chem. 44 (2001) 1151
20. Boeckler F., Ohnmacht U., Lehmann T., Utz W., Hübner H., and Gmeiner P. J. Med. Chem. 48 (2005) 2493
21. Cha M.Y., Lee I.Y., Cha J.H., Choi K.I., Cho Y.S., Koh H.Y., and Pae A.N. Bioorg. Med. Chem. 11 (2003) 1293
22. Hackling A., Ghosh R., Perachon S., Mann A., Holtje H.D., Wermuth C.G., Schwartz J.C., Sippl W., Sokoloff P., and Stark H. J. Med. Chem. 46 (2003) 3883
23. Sybyl 6.9, Tripos Inc., 1699 South Hanley Road, St. Louis, Missouri, 63144, U.S.A.
24. Clark M., Cramer III R.D., and Van Opdenbosch N. J. Comput. Chem. 10 (1989) 982
25. Gasteiger J., and Marsili M. Tetrahedron 36 (1980) 3219
26. Hinze J., and Jaffe H.H. J. Am. Chem. Soc. 84 (1962) 540
27. Stewart J.J. J. Comput. Aided Mol. Des. 4 (1990) 1
28. Stewart, J. J. P.; Frank, J. MOPAC, Seiler Bokstav Research Laboratory, United Air Force Academy, CO 80840.
29. ASP V3.22, Oxford Molecular Ltd, The Medawar Centre, Oxford Science Park, Sandford-on-Thames, Oxford OX4 4GA, U.K.
30. TSAR V3.2, Oxford Molecular Ltd, The Medawar Centre, Oxford Science Park, Sandford-on-Thames, Oxford OX4 4GA, U.K.
31. Beck B., Clark T., and Glen R.C. J. Mol. Model. 1 (1995) 176
32. Clark T., Alex A., Beck B., Chandrasekar J., Gedeck P., Horn A., Huttern M., Martin B., Rauhut G., Sauer W., Schindler T., and Steinke T. VAMP 7.0 Program Package (1998), Oxford Molecular Plc, Oxford
33. Tropsha A., and Cho S.J. In: Kubinyi H. (Ed). 3D QSAR in Drug Design Vol. 3 (1998), ESCOM, Leiden 57-69
34. Wang R., Gao Y., Liu L., and Lai L. J. Mol. Model. 4 (1998) 276
35. Wold S. Quant. Struct.-Act. Relat. 10 (1991) 191
36. Cramer III R.D., Patterson D.E., and Bunce J.D. J. Am. Chem. Soc. 110 (1988) 5959
37. Shao J. J. Am. State Assoc. 88 (1993) 486
38. Baroni M., Clementi S., Cruciani G., Costantino G., Riganelli D., and Oberrauch E. J. Chemom. 6 (1992) 347
39. Cruciani G., Baroni M., Clementi S., Costantino G., Riganelli D., and Skagerberg B. J. Chemom. 6 (1992) 335
40. Böhm M., Stürzebecher J., and Klebe G. J. Med. Chem. 42 (1999) 458
41. Thibaut U., Folkers G., Klebe G., Kubinyi H., Merz A., and Rognan D. In: Kubinyi H. (Ed). 3D QSAR in Drug Design. Theory, Methods and Applications (1993), ESCOM, Leiden, The Netherlands 711-716
42. Hattotuwagama C.K., Doytchinova I.A., and Flower D.R. J. Chem. Inf. Mod. 45 (2005) 1415
43. Bright, G. M.; Desai, K. A. WO9008148, 1990.
44. Hartwig J.F. Angew. Chem., Int. Ed. 37 (1998) 2046
45. Wolfe J.P., Tomori H., Sadighi J.P., Yin J., and Buchwald S.L. J. Org. Chem. 65 (2000) 1158
46. Hübner H., Haubmann C., Utz W., and Gmeiner P. J. Med. Chem. 43 (2000) 756
47. Lenz C., Haubmann C., Hübner H., Boeckler F., and Gmeiner P. Bioorg. Med. Chem. 13 (2005) 185
48. Schlotter K., Boeckler F., Hübner H., and Gmeiner P. J. Med. Chem. 48 (2005) 3696
49. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. J. Biol. Chem. 193 (1951) 265
50. Cheng Y., and Prusoff W.H. Biochem. Pharmacol. 22 (1973) 3099
51. Clark, R. D.; Sprous, D. G.; Leonard, J. M. In Rational Approaches to Drug Design; Hoeltje, H.-D., Sippl, W., Eds.; Prous Science SA: 2001; pp 475-485.